NMS (New Medicine Service)


Updated NMS service specification

NHSE&I have today published an updated draft version of the New Medicine Service (NMS) service specification. This service specification is currently working its way through the NHSE&I publication approval process, and the final version will be published in due course.

The updated service specification reflects the expansion of the service, which was one of the agreed outcomes from negotiations for Year 3 of the CPCF.

Community pharmacy contractors meeting the requirements for the provision of the NMS can start providing the expanded service from today (1st September 2021).

Download the updated NMS service specification

 

The New Medicine Service (NMS) was the fourth Advanced Service to be added to the NHS community pharmacy contract; it commenced on 1st October 2011.

The service provides support for people with long-term conditions newly prescribed a medicine to help improve medicines adherence; it is initially focused on particular patient groups and conditions.

An  e-learning package is now available at CPPE New Medicines Service e-learning programme : https://www.cppe.ac.uk/programmes/l/nms-e-01

Support Material:

Guidance for hospital pharmacists, doctors, nurses and NHS managers working in secondary care about community pharmacy services.

Guidance for community pharmacists about how to engage with hospital colleagues.

A standardised referral form that hospital pharmacists and others can complete when a patient is discharged.  This includes a feedback section that community pharmacists can send back to the referrer when they have asked for feedback.

A Leaflet (which can be amended for local use) for patients who are leaving hospital which outlines the services that they can receive from their community pharmacy.